Superficial Bladder Cancer Therapy

Bladder cancer treatment remains a challenge despite significant improvements in preventing disease progression and improving survival. Intravesical therapy has been used in the management of superficial transitional cell carcinoma (TCC) of the urinary bladder (i.e. Ta, T1, and carcinoma in situ) wi...

Full description

Saved in:
Bibliographic Details
Main Authors: Emmanuel Schenkman, Donald L. Lamm
Format: Article
Language:English
Published: Wiley 2004-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1100/tsw.2004.81
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550376546500608
author Emmanuel Schenkman
Donald L. Lamm
author_facet Emmanuel Schenkman
Donald L. Lamm
author_sort Emmanuel Schenkman
collection DOAJ
description Bladder cancer treatment remains a challenge despite significant improvements in preventing disease progression and improving survival. Intravesical therapy has been used in the management of superficial transitional cell carcinoma (TCC) of the urinary bladder (i.e. Ta, T1, and carcinoma in situ) with specific objectives which include treating existing or residual tumor, preventing recurrence of tumor, preventing disease progression, and prolonging survival. The initial clinical stage and grade remain the main determinant factors in survival regardless of the treatment. Prostatic urethral mucosal involvement with bladder cancer can be effectively treated with Bacillus Calmette-Guerin (BCG) intravesical immunotherapy. Intravesical chemotherapy reduces short-term tumor recurrence by about 20%, and long-term recurrence by about 7%, but has not reduced progression or mortality. Presently, BCG immunotherapy remains the most effective treatment and prophylaxis for TCC (Ta, T1, CIS) and reduces tumor recurrence, disease progression, and mortality. Interferons, Keyhole-limpet hemocyanin (KLH), bropirimine and Photofrin-Photodynamic Therapy (PDT) are under investigation in the management of TCC and early results are encouraging. This review highlights and summarizes the recent advances in therapy for superficial TCC.
format Article
id doaj-art-c4eb242d9c31457f8add8f269ba35a23
institution Kabale University
issn 1537-744X
language English
publishDate 2004-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-c4eb242d9c31457f8add8f269ba35a232025-02-03T06:06:58ZengWileyThe Scientific World Journal1537-744X2004-01-01438739910.1100/tsw.2004.81Superficial Bladder Cancer TherapyEmmanuel Schenkman0Donald L. Lamm1West Virginaia University, Morgantown, WV, USAWest Virginaia University, Morgantown, WV, USABladder cancer treatment remains a challenge despite significant improvements in preventing disease progression and improving survival. Intravesical therapy has been used in the management of superficial transitional cell carcinoma (TCC) of the urinary bladder (i.e. Ta, T1, and carcinoma in situ) with specific objectives which include treating existing or residual tumor, preventing recurrence of tumor, preventing disease progression, and prolonging survival. The initial clinical stage and grade remain the main determinant factors in survival regardless of the treatment. Prostatic urethral mucosal involvement with bladder cancer can be effectively treated with Bacillus Calmette-Guerin (BCG) intravesical immunotherapy. Intravesical chemotherapy reduces short-term tumor recurrence by about 20%, and long-term recurrence by about 7%, but has not reduced progression or mortality. Presently, BCG immunotherapy remains the most effective treatment and prophylaxis for TCC (Ta, T1, CIS) and reduces tumor recurrence, disease progression, and mortality. Interferons, Keyhole-limpet hemocyanin (KLH), bropirimine and Photofrin-Photodynamic Therapy (PDT) are under investigation in the management of TCC and early results are encouraging. This review highlights and summarizes the recent advances in therapy for superficial TCC.http://dx.doi.org/10.1100/tsw.2004.81
spellingShingle Emmanuel Schenkman
Donald L. Lamm
Superficial Bladder Cancer Therapy
The Scientific World Journal
title Superficial Bladder Cancer Therapy
title_full Superficial Bladder Cancer Therapy
title_fullStr Superficial Bladder Cancer Therapy
title_full_unstemmed Superficial Bladder Cancer Therapy
title_short Superficial Bladder Cancer Therapy
title_sort superficial bladder cancer therapy
url http://dx.doi.org/10.1100/tsw.2004.81
work_keys_str_mv AT emmanuelschenkman superficialbladdercancertherapy
AT donaldllamm superficialbladdercancertherapy